BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doi H, Iyer TK, Carpenter E, Li H, Chang KM, Vonderheide RH, Kaplan DE. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population. Hepatology. 2012;55:709-719. [PMID: 21932384 DOI: 10.1002/hep.24689] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Wirth TC. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies. Expert Rev Gastroenterol Hepatol. 2014;8:101-110. [PMID: 24410473 DOI: 10.1586/17474124.2014.862497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
2 Ramachandran P, Matchett KP, Dobie R, Wilson-Kanamori JR, Henderson NC. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat Rev Gastroenterol Hepatol 2020;17:457-72. [PMID: 32483353 DOI: 10.1038/s41575-020-0304-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 26.0] [Reference Citation Analysis]
3 Doi H, Hayashi E, Arai J, Tojo M, Morikawa K, Eguchi J, Ito T, Kanto T, Kaplan DE, Yoshida H. Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia. J Gastroenterol Hepatol 2018. [PMID: 29427373 DOI: 10.1111/jgh.14123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Doi H, Tanoue S, Kaplan DE. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol 2014;150:184-91. [PMID: 24434272 DOI: 10.1016/j.clim.2013.12.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
5 Abd El-Wahab EW, Metwally M, Lotfy N. Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies. Trop Med Int Health 2021;26:882-94. [PMID: 33860608 DOI: 10.1111/tmi.13588] [Reference Citation Analysis]
6 Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N. Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis: Predictive factors of tolvaptan efficacy for LC. Hepatol Res 2018;48:E311-9. [DOI: 10.1111/hepr.12988] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Chang LY, Li Y, Kaplan DE. Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis. Sci Rep 2016;6:36862. [PMID: 27857173 DOI: 10.1038/srep36862] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
8 Noor MT, Manoria P. Immune Dysfunction in Cirrhosis. J Clin Transl Hepatol. 2017;5:50-58. [PMID: 28507927 DOI: 10.14218/jcth.2016.00056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
9 López-Guerra D, Santos-Naharro J, Rojas-Holguín A, Jaen-Torrejimeno I, Prada-Villaverde A, Blanco-Fernández G. Postoperative bleeding and biliary leak after liver resection: A cohort study between two different fibrin sealant patches. Sci Rep 2019;9:12001. [PMID: 31427638 DOI: 10.1038/s41598-019-48529-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Albillos A, Lario M, Álvarez-mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. Journal of Hepatology 2014;61:1385-96. [DOI: 10.1016/j.jhep.2014.08.010] [Cited by in Crossref: 470] [Cited by in F6Publishing: 387] [Article Influence: 67.1] [Reference Citation Analysis]
12 Sood S, Yu L, Visvanathan K, Angus PW, Gow PJ, Testro AG. Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients. World J Hepatol 2016;8:1569-75. [PMID: 28050238 DOI: 10.4254/wjh.v8.i35.1569] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
13 Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310-1324. [PMID: 24530646 DOI: 10.1016/j.jhep.2014.01.024] [Cited by in Crossref: 464] [Cited by in F6Publishing: 383] [Article Influence: 66.3] [Reference Citation Analysis]
14 Lee HL, Bae SH, Jang B, Hwang S, Yang H, Nam HC, Sung PS, Lee SW, Jang JW, Choi JY, Han NI, Song BJ, Lee JW, Yoon SK. Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy.Gut Liver. 2017;11:870-877. [PMID: 28750484 DOI: 10.5009/gnl16434] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Shao Y, Lo CM, Ling CC, Liu XB, Ng KT, Chu AC, Ma YY, Li CX, Fan ST, Man K. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Lett 2014;355:264-72. [PMID: 25301451 DOI: 10.1016/j.canlet.2014.09.026] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 8.6] [Reference Citation Analysis]
16 Zhao S, Xu W, Xie YX, Chen WW, Zhao M. CXCR5+ CD4+ T cell subsets and their relationship to immune dysfunction in chronic hepatitis B-associated liver cirrhosis. J Gastroenterol Hepatol 2020;35:689-95. [PMID: 31519041 DOI: 10.1111/jgh.14866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol. 2014;20:2542-2554. [PMID: 24627590 DOI: 10.3748/wjg.v20.i10.2542] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 56] [Article Influence: 11.5] [Reference Citation Analysis]
18 Kalinina O, Louzoun Y, Wang Y, Utset T, Weigert M. Origins and specificity of auto-antibodies in Sm+ SLE patients. Journal of Autoimmunity 2018;90:94-104. [DOI: 10.1016/j.jaut.2018.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Talima S, Kassem H, Kassem N. Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.Breast Cancer. 2019;26:154-163. [PMID: 30191397 DOI: 10.1007/s12282-018-0904-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
20 Yang L, Seki E. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front Physiol 2012;3:138. [PMID: 22661952 DOI: 10.3389/fphys.2012.00138] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 8.9] [Reference Citation Analysis]
21 Cardoso CC, Matiollo C, Pereira CHJ, Fonseca JS, Alves HEL, Silva OMD, Menegassi VS, Schiavon LL, Santos-Silva MC. B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis. Clin Res Hepatol Gastroenterol 2021;45:101698. [PMID: 33852953 DOI: 10.1016/j.clinre.2021.101698] [Reference Citation Analysis]
22 Santer DM, Ma MM, Hockman D, Landi A, Tyrrell DL, Houghton M. Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis. PLoS One. 2013;8:e68308. [PMID: 23840845 DOI: 10.1371/journal.pone.0068308] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
23 Di Profio B, Villar CC, Saraiva L, Ortega KL, Pannuti CM. Is periodontitis a risk factor for infections in cirrhotic patients? Med Hypotheses 2017;106:19-22. [PMID: 28818265 DOI: 10.1016/j.mehy.2017.06.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Grønbæk L, Vilstrup H, Deleuran B, Wiest R, Krag A, Jepsen P. Alcoholic Cirrhosis Increases Risk for Autoimmune Diseases: A Nationwide Registry-Based Cohort Study. Clin Gastroenterol Hepatol 2015;13:2017-22. [PMID: 26044312 DOI: 10.1016/j.cgh.2015.05.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Jhun JY, Kim HY, Byun JK, Chung BH, Bae SH, Yoon SK, Kim DG, Yang CW, Cho M, Choi JY. B-cell–associated immune profiles in patients with decompensated cirrhosis. Scandinavian Journal of Gastroenterology 2015;50:884-91. [DOI: 10.3109/00365521.2014.907335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol. 2014;20:2564-2577. [PMID: 24627592 DOI: 10.3748/wjg.v20.i10.2564] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 68] [Article Influence: 15.5] [Reference Citation Analysis]
27 Roberts ME, Kaminski D, Jenks SA, Maguire C, Ching K, Burbelo PD, Iadarola MJ, Rosenberg A, Coca A, Anolik J, Sanz I. Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells. Arthritis Rheumatol 2014;66:2558-69. [PMID: 24909310 DOI: 10.1002/art.38734] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
28 Tsiaoussis GI, Assimakopoulos SF, Tsamandas AC, Triantos CK, Thomopoulos KC. Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications. World J Hepatol. 2015;7:2058-2068. [PMID: 26301048 DOI: 10.4254/wjh.v7.i17.2058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
29 Tedesco D, Grakoui A. Environmental peer pressure: CD4+ T cell help in tolerance and transplantation. Liver Transpl 2018;24:89-97. [PMID: 28926189 DOI: 10.1002/lt.24873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
30 Zhang M, Zhang L, Li H, Chen Z, Luo A, Liu B, Chen M, Peng M, Ren H, Hu P. Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy. Int Immunopharmacol 2016;34:235-43. [PMID: 26971227 DOI: 10.1016/j.intimp.2016.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
31 Abdelwahab FA, Hassanein KM, Hetta HF, Abdelmalek MO, Zahran AM, El-Badawy O. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus. Sci Rep 2020;10:20383. [PMID: 33230233 DOI: 10.1038/s41598-020-77416-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
32 Acharya C, Bajaj JS. Altered Microbiome in Patients With Cirrhosis and Complications. Clin Gastroenterol Hepatol 2019;17:307-21. [PMID: 30099098 DOI: 10.1016/j.cgh.2018.08.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 15.3] [Reference Citation Analysis]
33 Cereceda-Monteoliva N, Lewis H, Al-Himdani S, Stone C. Periorbital necrotising fasciitis with underlying undiagnosed hepatitis C infection. BMJ Case Rep 2019;12:e223720. [PMID: 31015232 DOI: 10.1136/bcr-2017-223720] [Reference Citation Analysis]
34 Basho K, Zoldan K, Schultheiss M, Bettinger D, Globig AM, Bengsch B, Neumann-Haefelin C, Klocperk A, Warnatz K, Hofmann M, Thimme R, Boettler T. IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis. J Hepatol 2021;74:649-60. [PMID: 33211012 DOI: 10.1016/j.jhep.2020.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
35 Moratalla A, Caparrós E, Juanola O, Portune K, Puig-Kröger A, Estrada-Capetillo L, Bellot P, Gómez-Hurtado I, Piñero P, Zapater P, González-Navajas JM, Such J, Sanz Y, Francés R. Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis. J Hepatol 2016;64:135-45. [PMID: 26334579 DOI: 10.1016/j.jhep.2015.08.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
36 Borhis G, Richard Y. Subversion of the B-cell compartment during parasitic, bacterial, and viral infections. BMC Immunol 2015;16:15. [PMID: 25884828 DOI: 10.1186/s12865-015-0079-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
37 Thapa M, Tedesco D, Gumber S, Elrod EJ, Han JH, Kitchens WH, Magliocca JF, Adams AB, Grakoui A. Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease. J Immunol 2020;204:3117-28. [PMID: 32332110 DOI: 10.4049/jimmunol.1900391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Huang C, Shao J, Lou C, Wu F, Ge T, Gao H, Zheng X, Dong X, Xu L, Chen Z. Reduced Energy Metabolism Impairs T Cell-Dependent B Cell Responses in Patients With Advanced HBV-Related Cirrhosis. Front Immunol 2021;12:660312. [PMID: 34248941 DOI: 10.3389/fimmu.2021.660312] [Reference Citation Analysis]
39 Bozward AG, Warricker F, Oo YH, Khakoo SI. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade. Front Immunol 2021;12:643310. [PMID: 33995362 DOI: 10.3389/fimmu.2021.643310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
40 Kaplan DE. Immunopathogenesis of Hepatitis C Virus Infection. Gastroenterol Clin North Am 2015;44:735-60. [PMID: 26600217 DOI: 10.1016/j.gtc.2015.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
41 Bernsmeier C, Singanayagam A, Patel VC, Wendon J, Antoniades CG. Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure. Immunotherapy. 2015;7:641-654. [PMID: 26065379 DOI: 10.2217/imt.15.27] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
42 Huang M, Liu X, Ye H, Zhao X, Zhao J, Liu Y, He X, Qu M, Pan J, Hou B, Cheng Y, Liu Z, Li Z, Liu L, Sun J, Zhang S, Zhang Z. Metabolic defects in splenic B cell compartments from patients with liver cirrhosis. Cell Death Dis 2020;11:915. [PMID: 33099582 DOI: 10.1038/s41419-020-03060-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lurje I, Hammerich L, Tacke F. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer. Int J Mol Sci 2020;21:E7378. [PMID: 33036244 DOI: 10.3390/ijms21197378] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
44 Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology. 2012;56:1567-1574. [PMID: 22378061 DOI: 10.1002/hep.25674] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
45 Moustafa H, Madkour M, Hamed F, Abouelnazar S, Abo Elwafa R, Moaaz M. Modulation of Memory B Cell Phenotypes and Toll-Like Receptor-7 in Chronic Hepatitis C Virus Infection During Direct-Acting Antiviral Interferon-Free Therapy: Correlation with Interleukin-7. Viral Immunol 2021;34:227-40. [PMID: 33180667 DOI: 10.1089/vim.2020.0110] [Reference Citation Analysis]
46 Zhao J, Shi J, Qu M, Zhao X, Wang H, Huang M, Liu Z, Li Z, He Q, Zhang S, Zhang Z. Hyperactive Follicular Helper T Cells Contribute to Dysregulated Humoral Immunity in Patients With Liver Cirrhosis. Front Immunol 2019;10:1915. [PMID: 31456809 DOI: 10.3389/fimmu.2019.01915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Ashhab AA, Rodin H, Campos M, Abu-Sulb A, Hall JA, Powell J, Debes JD. Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection. PLoS One 2020;15:e0237398. [PMID: 32845914 DOI: 10.1371/journal.pone.0237398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
48 Hetta HF, Zahran AM, Mansor SG, Abdel-Malek MO, Mekky MA, Abbas WA. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma. J Med Virol 2019;91:1319-28. [PMID: 30761547 DOI: 10.1002/jmv.25428] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
49 McDonnell ME, Ganley-Leal LM, Mehta A, Bigornia SJ, Mott M, Rehman Q, Farb MG, Hess DT, Joseph L, Gokce N, Apovian CM. B lymphocytes in human subcutaneous adipose crown-like structures. Obesity (Silver Spring) 2012;20:1372-8. [PMID: 22395812 DOI: 10.1038/oby.2012.54] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
50 Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197-209. [PMID: 23993913 DOI: 10.1016/j.jhep.2013.07.044] [Cited by in Crossref: 398] [Cited by in F6Publishing: 324] [Article Influence: 49.8] [Reference Citation Analysis]
51 Ozeki I, Nakajima T, Suii H, Tatsumi R, Yamaguchi M, Kimura M, Arakawa T, Kuwata Y, Ohmura T, Hige S, Karino Y, Toyota J. Analysis of hepatitis B surface antigen (HBsAg) using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays: High-sensitivity HBsAg assays. Hepatol Res 2018;48:E263-74. [DOI: 10.1111/hepr.12979] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]